Medical device maker Hologic Inc. has agreed to buy diagnostic test maker Gen-Probe Inc. for about $3.72 billion, expanding its portfolio in an area of medicine expected to see big growth. Gen-Probe ...
BRUSSELS, June 3 (Reuters) - U.S. disease diagnosis firm Gen-Probe Inc launched a 215 million euro ($335.4 million) counterbid for Belgian peer Innogenetics NV on Tuesday, trumping an offer from local ...
Xceed Molecular, a Canadian firm with offices in Wellesley, says it has granted Gen-Probe Inc. a non-exclusive license to use Xceed’s Flow-Thru Chip technology for gene analysis. According to ...
Test aims to help clinicians decide whether patients who test negative will need further biopsy procedures. FDA approved Gen-Probe’s Progensa® PCA3 (Prostate Cancer gene 3) assay, which the firm ...
today provided an update regarding Hologic's previously announced acquisition of Gen-Probe. Gen-Probe has scheduled a Special Meeting of Stockholders for July 31, 2012 to vote on the pending ...
Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected] ...
LONDON (CBS.MW) -- J.P. Morgan Securities cut its rating on Gen-Probe to neutral from overweight, citing valuation. The biotech stock has "increased 182 percent year to date versus an average 59 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results